These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2307155)

  • 1. Plasma level distribution, effect and toxicity of antiepileptic drugs among Ethiopian epileptics.
    Bekele G; Abebe Y; T'Haimanot R
    Ethiop Med J; 1990 Jan; 28(1):23-30. PubMed ID: 2307155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic TDM pattern at a tertiary care hospital in India.
    Jose VM; Medhi B; Pandhi P
    Nepal Med Coll J; 2006 Jun; 8(2):107-10. PubMed ID: 17017400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of drug therapy in epileptic children.
    Singh LM; Mehta S; Vohra RM; Nain CK
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):251-4. PubMed ID: 3596850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum protein binding of antiepileptic drugs in Sri Lankans.
    Karunanayake EH; Joice PD; Peiris JB; Meijer JW; Meinardi H
    Ceylon Med J; 1990 Mar; 35(1):25-8. PubMed ID: 2361227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Proc Aust Assoc Neurol; 1976; 13():89-96. PubMed ID: 1029012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction of single doses of quinine and carbamazepine, phenobarbitone and phenytoin in healthy volunteers.
    Amabeoku GJ; Chikuni O; Akino C; Mutetwa S
    East Afr Med J; 1993 Feb; 70(2):90-3. PubMed ID: 8513749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum levels during prolonged combination therapy with phenytoin and phenobarbitone.
    Müller FO; Aucamp AK; Hundt HK; Steyn JM; Olivier LR; Wessels WH
    S Afr Med J; 1977 Aug; 52(9):356-8. PubMed ID: 897947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consequeces of the elimination of a combination drug. Transition from combination antisacer: attention].
    de Crousaz G; Schelling JL
    Schweiz Med Wochenschr; 1977 Dec; 107(51):1932-6. PubMed ID: 594737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels.
    Callaghan N; Feely M; Duggan F; O'Callaghan M; Seldrup J
    Acta Neurol Scand; 1977 Jul; 56(1):1-6. PubMed ID: 878841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH; Ahmed MM; Mohammed SA
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NONMEM approach for estimating population pharmacokinetic parameters of phenytoin in Chinese epileptics].
    Rui JZ; Cai MH; Chu XM; Chen G
    Yao Xue Xue Bao; 1995; 30(3):172-8. PubMed ID: 7639079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D.
    Davie MW; Emberson CE; Lawson DE; Roberts GE; Barnes JL; Barnes ND; Heeley AF
    Q J Med; 1983; 52(205):79-91. PubMed ID: 6603629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy.
    Gough H; Goggin T; Bissessar A; Baker M; Crowley M; Callaghan N
    Q J Med; 1986 Jun; 59(230):569-77. PubMed ID: 3092278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC
    J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radioimmunologic study of the plasma concentrations of folic acid and various antiepileptic preparations during the treatment of epileptic patients].
    Boldarov AI; Maĭzelis MIa; Vaĭntrub MIa; Zabludovskiĭ AL; Gvirtsman LE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):845-8. PubMed ID: 6880514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
    Sobaniec W
    Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.